Ding Xiong, Lu Chang-You, Mei Ying, Liu Chang-An, Shi Yu-Jun
Department of Hepatobiliary Surgery, the Second Clinical College, Chongqing Medical University, 74 Linjiang Road, Chongqing 400010,China.
Hepatobiliary Pancreat Dis Int. 2005 May;4(2):295-8.
The incidence of gallstone is higher in patients with diabetes mellitus than in general population because of hypomotility and lowered emptying function. The aim of this study was to investigate the gene expression of cholecystokinin-A (CCK-A) receptor in patients with gallstones and diabetes mellitus and its correlation with the hypomotility of the gallbladder.
Smooth muscle was taken from the gallbladder after cholecystectomy and total RNA was extracted from it by Trizol reagent to compose cDNA. CCK-A receptor was enlarged by reverse transcription-polymerase chain reaction (RT-PCR) and identified by electrophoresis. Based on the analysis of images, the relative expression of the CCK-A receptor was obtained after comparison of the CCK-A receptor and beta-action. The emptying function of the gallbladder was measured with B ultrasound before operation.
Gallbladder ejection fraction (GBEF2) (%) (24.9+/-12.7) decreased more significantly in patients with gallstones and diabetes mellitus than in those with simple gallstone (61.5+/-8.5) (P<0.01). In the two groups, a fraction of 540bp of CCK-A receptor could be testified respectively, but the relative expression was different. Compared to the expression of beta-action, it was 0.400+/-0.068 in patients with gallstones and diabetes mellitus, but 0.622+/-0.070 in those with gallstone only (F=7.169, Pu0.01). The result was consistent with the decreased contractility.
The gene expression of CCK-A receptor on the smooth muscle of the gallbladder may decrease more significantly in patients with gallstone and diabetes mellitus than in those with gallstone only; this result is consistent with the decreased motility. Thus the lowered expression of CCK-A receptor is probably the cause of hypomotility in patients with gallstones and diabetes mellitus.
由于胆囊运动减弱和排空功能降低,糖尿病患者胆结石的发病率高于普通人群。本研究旨在探讨胆结石合并糖尿病患者胆囊收缩素A(CCK-A)受体的基因表达及其与胆囊运动减弱的相关性。
胆囊切除术后取胆囊平滑肌,用Trizol试剂提取总RNA并合成cDNA。通过逆转录聚合酶链反应(RT-PCR)扩增CCK-A受体并进行电泳鉴定。基于图像分析,比较CCK-A受体和β-肌动蛋白后获得CCK-A受体的相对表达。术前用B超测量胆囊排空功能。
胆结石合并糖尿病患者的胆囊排空分数(GBEF2)(%)(24.9±12.7)较单纯胆结石患者(61.5±8.5)下降更显著(P<0.01)。两组均可检测到540bp的CCK-A受体片段,但相对表达不同。与β-肌动蛋白的表达相比,胆结石合并糖尿病患者为0.400±0.068,而单纯胆结石患者为0.622±0.070(F=7.169,P<0.01)。结果与收缩力降低一致。
胆结石合并糖尿病患者胆囊平滑肌上CCK-A受体的基因表达可能比单纯胆结石患者下降更显著;这一结果与运动减弱一致。因此,CCK-A受体表达降低可能是胆结石合并糖尿病患者运动减弱的原因。